Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb - Concepedia

Concepedia

Publication | Closed Access

Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb

60

Citations

35

References

2007

Year

Betty Li, Jianmin Lin, Melinda VanRoey, Maria Jure–Kunkel, Karin Jooss

Clinical Immunology

Cancer ImmunosurveillanceB16 TumorsMedicineImmunologyTumor ImmunityAnti-4-1bb MabImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1